Chronicle_2B | R Documentation |
Kaplan-Meier digitized data from Chronicle, figure 2B (PMID 24718885). A reported sample size of 113 for a primary endpoint of DFS in colorectal cancer.
Chronicle_2B
A data frame of 113 observations and 3 variables:
time | event time (in months) | |
event | OS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (capecitabine_oxaliplatin, follow_up_only) | |
Glynne-Jones R, Counsell N, Quirke P, et al. Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control. Ann Oncol 2014; 25: 1356–62.
summary(Chronicle_2B)
kmplot(Chronicle_2B)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.